Curaleaf Holdings (CURLF) Income from Continuing Operations (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Income from Continuing Operations of 127334000.0 in Q1 2026, down 111.69% quarter-over-quarter from 1089000000.0 in Q4 2025, and down 838.04% on a YoY basis from 17253000.0 in Q1 2025.
Curaleaf Holdings (CURLF) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 127334000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 838.04% year-over-year to 127334000.0; the TTM figure through Mar 2026 stood at 13127596000.0 (up 5987.05% YoY), while the FY2025 annual figure was 201903000.0, up 4.59% from the prior year.
- Income from Continuing Operations was 127334000.0 for Q1 2026 at Curaleaf Holdings, down from 1089000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12160000000.0 in Q2 2025 to a low of 63600000000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 2984202823.53 across 5 years, with a median of 17253000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations tumbled 26884.25% in 2023, then jumped 85359.27% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 235693000.0 in 2022, then sank by 26884.25% to 63600000000.0 in 2023, then soared by 99.57% to 275257000.0 in 2024, then jumped by 495.63% to 1089000000.0 in 2025, then plunged by 111.69% to 127334000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 127334000.0 (Q1 2026), 1089000000.0 (Q4 2025), and 5930000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -127.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.33 Mn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 12.16 Bn |
| Mar 31, 2025 | 17.25 Mn |
| Dec 31, 2024 | -275.26 Mn |
| Sep 30, 2024 | 20.78 Mn |
| Jun 30, 2024 | 14.23 Mn |
| Mar 31, 2024 | 28.60 Mn |
| Dec 31, 2023 | -63.60 Bn |
| Sep 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | 17.31 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -235.69 Mn |
| Sep 30, 2022 | 58.52 Mn |
| Jun 30, 2022 | 81.06 Mn |
| Mar 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | -5.24 Mn |
| Sep 30, 2021 | 62.95 Mn |
| Jun 30, 2021 | 76.97 Mn |